<p>Inject Liraglutide subcutaneously once-daily at any time of day, independently of meals. Initiate Liraglutide with a dose of 0.6 mg per day for one week. The 0.6 mg dose is a starting dose intended to reduce gastrointestinal&nbsp;symptoms during initial titration, and is not effective for glycemic control. After one week at 0.6 mg per day, the dose should be increased to 1.2 mg. If the 1.2 mg dose does not result in acceptable glycemic control, the dose can be increased to 1.8 mg. If a dose is missed, resume the once-daily regimen as prescribed with the next scheduled dose. Do not administer an extra dose or increase in dose to make up for the missed dose.<br />
<br />
If more than 3 days have elapsed since the last Liraglutide dose, reinitiate Liraglutide at 0.6 mg to mitigate any gastrointestinal symptoms associated with reinitiation of treatment. Upon reinitiation, Liraglutide should be titrated at the discretion of the prescriber.</p>

<p>&nbsp;</p>

<p><strong>Administration</strong></p>

<ul>
	<li>Inspect visually prior to each injection. Only use if solution is clear, colorless, and contains no particles.</li>
	<li>Inject Liraglutide subcutaneously in the abdomen, thigh or upper arm. No dose adjustment is needed if changing the injection site and/or timing.</li>
	<li>When using Liraglutide with insulin, administer as separate injections. Never mix.</li>
	<li>It is acceptable to inject Liraglutide and insulin in the same body region but the injections should not be&nbsp;adjacent&nbsp;to each other.</li>
</ul>